FDA WARNING_LETTER - SCM True Air Technologies LLC - May 24, 2013
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On May 6-24, 2013, an FDA inspection of SCM True Air Technologies, Inc. in Louisville, KY, revealed that their bariatric beds and low air loss controllers are adulterated under 21 U.S.C. § 351(h) due to non-conformity with Current Good Manufacturing Practice (CGMP) requirements of the Quality System (QS) regulation (21 CFR Part 820).
Key violations include: 1. Failure to control nonconforming product (21 CFR 820.90(a)): Procedures were inadequate, and 34 of 48 nonconforming beds were not evaluated or investigated. 2. Failure to establish complaint handling procedures (21 CFR 820.198(a)): A complaint regarding 48 bariatric beds with defects was not entered into the system. 3. Inadequate design input procedures (21 CFR 820.30(c)): Design procedures lacked defined performance, safety, environmental, and physical characteristics, and were not fully implemented. 4. Inadequate design output procedures (21 CFR 820.30(d)): Procedures lacked acceptance criteria, and design outputs like instructions for use and specifications were incomplete. 5. Failure to verify device design (21 CFR 820.30(f)):
ID · 63e0cd22-da38-41f8-bc4e-4587f9cd2dc1
Full citation text and observation details available on the Dashboard.